LC-MS/MS-ESI method for simultaneous quantitation of three endocannabinoids and its application to rat pharmacokinetic studies

Bioanalysis

Volumn 3, Issue 2, 2011, Pages 181-196

  Sharma, Kuldeep ^a   Singh, Radhe Raman ^a   Kandaswamy, Murugesh ^a   Mithra, Chandan ^a   Giri, Sanjeev ^a   Rajagopal, Sriram ^a   Mullangi, Ramesh ^a  

^a JUBILANT BIOSYS LTD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; ENDOCANNABINOID; N OLEOYLETHANOLAMINE; PALMIDROL;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CALIBRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILUTION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRECIPITATION; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY AND SPECIFICITY;

ANIMALS; ARACHIDONIC ACIDS; CHROMATOGRAPHY, LIQUID; ENDOCANNABINOIDS; ETHANOLAMINES; PALMITIC ACIDS; RATS; REFERENCE STANDARDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 79951935233     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.192     Document Type: Article

References (19)

1. Piomelli D. The endocannabinoid system: a drug discovery perspective. Curr. Opin. Investig. Drugs 6(7), 672-679 (2005). (Pubitemid 40904037)
2. Cota D, Marsicano G, Tschöp M et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 12(3), 423-431 (2003). (Pubitemid 38063771)
3. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346(6284), 561-564 (1990).
4. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365(6441), 61-65 (1993). (Pubitemid 23305569)
5. Cravatt BF, Giang DK, Mayfeld SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384(6604), 83-87 (1996). (Pubitemid 26374593)
6. Hardison S, Weintraub ST, Giuffrida A. Quantifcation of endocannabinoids in rat biological samples by GC-MS: technical and theoretical considerations. Prostaglandins Other Lipid Mediat. 81(3-4), 106-112 (2006). (Pubitemid 44666493)
7. Patel S, Wohlfeil ER, Rademacher DJ et al. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br. J. Pharmacol. 139(5), 1005-1013 (2003). (Pubitemid 36877399)
8. Di Marzo V, Breivogel CS, Tao Q et al. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 75(6), 2434-2444 (2000).
9. Cabranes A, Venderova K, de Lago E et al. Decreased endocannabinoid levels in the brain and benefcial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Neurobiol. Dis. 20(2), 207-217 (2005). (Pubitemid 41476248)
10. Richardson D, Ortori CA, Chapman V, Kendall DA, Barrett DA. Quantitative profling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal. Biochem. 360(2), 216-226 (2007). (Pubitemid 44958332)
11. Ahn K, Johnson DS, Mileni M et al. Discovery and characterization of a highly selective FAAH inhibitor that reduces infammatory pain. Chem. Biol. 16(4), 411-420 (2009).
12. Balvers MG, Verhoeckx KC, Witkamp RF. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(14-15), 583-1590 (2009).
13. Jian W, Edom R, Weng N, Zannikos P, Zhang Z, Wang H. Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878(20), 1687-1699 (2010).
14. Palandra J, Prusakiewicz J, Ozer JS, Zhang Y, Heath TG. Endogenous ethanolamide ana lysis in human plasma using HPLC-tandem MS with electrospray ionization. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(22), 2052-2060 (2009).
15. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin. Chem. 43(7), 1209-1214 (1997). (Pubitemid 27297265)
16. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for industry: bioanalytical method validation. (2001).
17. Bonfglio R, King RC, Olah TV, Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 13(12), 1175-1185 (1999). (Pubitemid 29285118)
18. Valenti M, Viganò D, Casico MG et al. Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell Mol. Life Sci. 61(7-8), 945-950 (2004). (Pubitemid 38651009)
19. Murillo-Rodriguez E, Désarnaud F, Prospéro-García O. Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. Life Sci. 79(1), 30-37 (2006).